Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Repurposing live attenuated trivalent MMR vaccine as cost-effective cancer immunotherapy

Frontiers in Oncology(2022)10.3389/fonc.2022.1042250Source: DataRank Database

Repurposing live attenuated trivalent MMR vaccine as cost-effective cancer immunotherapy is a research paper published in Frontiers in Oncology (2022). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

Linked data & code

pxd

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 1.01)OA: goldTopics (28)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (22)

Musa Gabere ORCID,Mika Taylor,Camila Simões ORCID,Chelsae Dumbauld,Oumar Barro

Live enrichment

PubMed:36457491 PMC:PMC9706410 OpenAlex:https://openalex.org/W4308723437

BLRD VA

Grant: I01 BX002425

National Institutes of Health

Grant: 1R24GM137786-01

IDeA National Resource for Quantitative Proteomics

National Institutes of Health

Grant: 7K01CA234324-04

cGAS-STING Pathway Targeting Replicative Adenoviruses with CD46 Tropism and AFP Promoter Conditional Replication Restriction for the Treatment of Hepatocellular Carcinoma

National Institutes of Health

Grant: 5P20GM121293-05

Center for Translational Pediatric Research (CTPR)

FWCI

1.01

Citation Percentile

0.8%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.3389/fonc.2022.1042250

publisherhttps://doi.org/10.3389/fonc.2022.1042250

publisherhttps://www.frontiersin.org/articles/10.3389/fonc.2022.1042250/full

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36457491

repositoryhttps://doaj.org/article/cc4969f03b474994ad64d25b34a6caa6

Fields of Study

Virus-based gene therapy researchImmunotherapy and Immune ResponsesViral gastroenteritis research and epidemiology0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

Oncolytic virusMedicineImmunotherapyTumor microenvironmentCancer vaccineCancerCancer researchImmunologyCancer immunotherapyImmune systemOvarian cancerInternal medicineHepatocellular carcinomalive attenuated vaccineColorectal CancerMeaslesMumpsOncolytic Viral TherapyRubella (Mmr) VaccineOncologyNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Repurposing live attenuated trivalent MMR vaccine as cost-effective cancer immunotherapy

FAIR Checklist

Authors (22)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)